Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 262.36M | $ 104.47M | 39.82% |
3/31/2025 | $ 321.43M | $ 66.43M | 20.67% |
12/31/2024 | $ 387.21M | $ 62.04M | 16.02% |
9/30/2024 | $ 451.83M | $ 160.96M | 35.62% |
6/30/2024 | $ 489.04M | $ 169.36M | 34.63% |
3/31/2024 | $ 403.4M | $ 154.06M | 38.19% |
12/31/2023 | $ 470.74M | $ 153.73M | 32.66% |
9/30/2023 | $ 431.73M | $ 48.64M | 11.27% |
6/30/2023 | $ 464.9M | $ 56.87M | 12.23% |
3/31/2023 | $ 358.02M | $ 74.55M | 20.82% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for SUTRO BIOPHARMA INC is calculated as follows: GP [ $ 45.75M ] / Assets [ $ 307.24M ]
(=) GPA [ 14.89% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |